プロタミンと亜鉛の結合によるインスリンアナログに対する構成効果:統合された実験的および計算的研究
Pooja Dahiya1, Priyanka Yadav2, Ankit Singh1
1School of Physical Sciences, Jawaharlal Nehru University, New Delhi-110067, India. mundemanoj@gmail.com.
Physical chemistry chemical physics : PCCP
|August 26, 2025
まとめ
亜鉛はインスリン類のリスプロとアスパルトを安定させる. 亜鉛アスパルトは亜鉛リスプロよりも安定したヘクサマーを形成し,インスリン治療の改善のためのプロタミン結合と配方ダイナミクスを影響する.
科学分野:
- 生物化学
- 医薬品科学
- 材料科学
背景:
- インスリン類は糖尿病の管理に不可欠であり,その作用時間は配方によって影響されます.
- 亜鉛は,最も安定したインスリン構造であるヘクサマー形成を促進することによってインスリンを安定させることが知られている.
- 亜鉛と無亜鉛のインスリンアナログの構成動態を理解することは,製法を最適化するための鍵です.
研究 の 目的:
- 亜鉛の存在と欠如におけるインスリンアナログであるリスプロとアスパルトの構造動態を調査する.
- 常用成分であるプロタミンとの相互作用を研究する.
- リスプロとアスパルトの安定性とプロタミン結合の違いの構造的根拠を解明する.
主な方法:
- ヘクサマーの安定性を評価するためのテルピリジン誘発解離実験.
- アトミック・フォース・顕微鏡 (AFM) で,アセンブリの異質性を分析する.
- 環状二重化 (CD) スペクトロスコーピーは,螺旋状の内容を決定する.
- 構造と動的洞察のための分子ダイナミクス (MD) シミュレーション.
- プロタミン結合研究のためのアイソテルミック・タイトレーション・カロメトリー (ITC) と光スペクトロスコーピー.
- 形状の変化を検出するためのANS結合測定法.
主要な成果:
- 亜鉛結合インスリン類型 (リスプロとアスパート) は,亜鉛のない同類型よりも安定しています.
- 亜鉛アスパルトは,亜鉛リスプロに比べて,より安定した一貫したヘクサメリック構造を形成し,異質性が高い.
- プロタミンは,亜鉛-リスプロよりも安定した亜鉛-アスパート・ヘクサマーに強く結合し,水素結合が増加することが観察されました.
- 両方とも,プロタミンの相互作用により構造変化を起こし,水害性残留物を露出する.
結論:
- 亜鉛アスパートは,亜鉛リスプロよりも優れた六合体安定性と構造の一貫性を示しています.
- プロタミンは,より安定した亜鉛アスパート六合体と好ましい相互作用をしており,その構造的整合性と極性による可能性が高い.
- これらの発見は,インスリンアナログの構造-機能関係に関する重要な洞察を提供し,高度なインスリン製剤の設計に情報を提供する.
関連する概念動画
Insulin: Biosynthesis, Chemistry, and Preparation
523
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
523
Insulin Formulations: Types and Delivery
270
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
270
Factors Affecting Protein-Drug Binding: Drug Interactions
273
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
273
Insulin: Dosing Regimen and Adverse Effects
257
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
257
Protein and Protein Structure
81.3K
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
A protein's shape is critical to its function. For example, an enzyme...
81.3K
Factors Affecting Protein-Drug Binding: Drug-Related Factors
195
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
195


